Green Point Research (GPR) is a vertically-integrated hemp biomass originator and processor. GPR aims to bring human, natural, and financial resources together to develop and supply new products, eco-friendly technology, and innovative strategies to the hemp industry and, in turn, grow successful businesses and communities. GPR currently offers for sale compliant bulk products including CBD rich biomass, processed hemp, and CBD extracts in isolate, distillate and crude oil, as well as white label offerings. Additionally, GPR has a line of bulk novel cannabinoids available for sale, including Delta 8 (Clear, Gold or Amber), THC-O, and HHC. Through constant innovation and dedication to genetic and supply chain improvement, GPR is working to become the world’s leader in hemp biomass origination and processing. It has farming operations and cultivars adapted to grow in every medium, climate, and lighting condition. GPR is currently in partnership with the University of Florida for an industrial hemp pilot project aiming to revitalize waning aspects of Florida’s agriculture sector. Further, GPR supports research initiatives ranging from innovative agricultural practices, to the efficacy of cannabinoid-based therapies to combat opioid dependency reduction and other medical crises. Founded in 2016, GPR helps combat such global issues as sustainable agriculture, affordable medicine, and a renewable supply chain. It is a large-scale operation with its national corporate headquarters based in Jasper, FL, and Latin American corporate headquarters in Bogotá, Colombia. To learn more about Green Point Research, please visit https://greenpointresearch.com.